… that have antibody-escape mutations and the potential for antibody-… representative
SARS-CoV-2 neutralizing antibodies that have … of COVID-19 preventive or therapeutic antibodies. …

… RBD-specific monoclonal antibodies derived from single B cells from 8 individuals infected
with SARS-CoV-2. We identified antibodies that potently neutralize SARS-CoV-2; this activity …

… Age did not appear to compromise antibody responses, even … SARS-CoV-2 infection elicits
robust neutralizing antibody … that SARS-CoV-2 infection elicits robust neutralizing antibody …

… the structural correlates of SARS-CoV-2 neutralization, we … neutralizing antibodies 5 in complex
with the SARS-CoV-2 … the antibodies into categories: (1) neutralizing antibodies encoded …

… suggest that SARS-CoV-2 subspecies with the RBD mutations Y453F or N501Y partially
escaped detection by 4 neutralizing monoclonal antibodies and 21 neutralizing antibodies in …

… to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains … anti–SARS-CoV-2
antibody response. They found that neutralizing antibody titers against the SARS-CoV-2 …

… been the development of broadly neutralizing antibodies for prophylactic and therapeutic
use. … we summarize neutralizing antibodies that target four key regions within the SARS-CoV-2 …

… of IgA, IgM and IgG antibodies, and we explore their roles in neutralising SARS-CoV-2, their
… Furthermore, we also review the applications of neutralising antibodies in the clinical setting…

… neutralizing activity, are less affected by Omicron, but a subset of neutralizing antibodies are
… Furthermore, Omicron pseudovirus neutralization showed that neutralizing antibodies that …

… In contrast to the antibodies from convalescent patient, in our lab, three potent SARS-CoV-2
neutralizing antibodies were screened from a combinatorial naïve library established 20 …